A
Novartis, Speaker:
Honoraria
celgene, speaker: Honoraria
jazz, speaker: Honoraria
Seattle Genetics, Speaker: Honoraria
Pharmacyclics, Speaker: Honoraria
Incyte, Speaker: Honoraria
celgene, speaker: Honoraria
jazz, speaker: Honoraria
Seattle Genetics, Speaker: Honoraria
Pharmacyclics, Speaker: Honoraria
Incyte, Speaker: Honoraria
Nothing to Disclose
Nothing to Disclose
Novartis, None:
Research Funding
Teva, None: Research Funding and Speakers Bureau
Teva, None: Research Funding and Speakers Bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Study Investigator:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celegen, Speaker:
Honoraria
Teva, Speaker: Honoraria
Teva, Speaker: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Millennium Pharmaceuticals, Independent Contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pfizer, Speaking:
Honoraria
GSK, independent contractor: Honoraria
Amgen, consulting: Honoraria
GSK, independent contractor: Honoraria
Amgen, consulting: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
NovImmune, Scientific Steering Committee:
Unpaid consultant for the Scientific Steering Committee for the 0501 Clinical Trial
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Viracor Eurofins, employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Takeda/BMS/Gilead, Advisory Board:
Advisory Board
OTSUKA AMERICA PHARMACEUTICAL, None:
Honoraria
Nothing to Disclose
Nothing to Disclose
Merck & Co., Inc., employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gentium/Jazz Pharmaceuticals, Support:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Study Investigator:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Oxford Immunotec, Research:
Research Funding
Oxford Immunotec, Research funding: Research Funding
Oxford Immunotec, Research funding: Research Funding
Bristol-Myers Squibb, Merck, Infinity, Consultant/advisor:
Advisory Board
and
Consultancy
Bristol-Myers Squibb, Sequenta, Otsuka, Sigma Tau, Tensha, Recevied research funding: Research Funding
Bristol-Myers Squibb, Sequenta, Otsuka, Sigma Tau, Tensha, Recevied research funding: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis Pharmaceuticals Corporation, Chief Medical officer:
Employee
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Takeda Oncology, Investigator/Consultancy/Advisory Role:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Miltenyi Biotech, None:
Research Funding
miltenyi biotech, research: Research Funding
miltenyi biotech, research: Research Funding
Chimerix Inc., consultant/investigator:
Consultancy
and
Research Funding
GlaxoSmithKline, investigator: Research Funding
Merck & Co., Inc., consultant/investigator: Consultancy and Research Funding
Novartis, consultant: Consultancy
GlaxoSmithKline, investigator: Research Funding
Merck & Co., Inc., consultant/investigator: Consultancy and Research Funding
Novartis, consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Shire Pharmaceuticals, Advisory Board:
Honoraria
Nothing to Disclose
Oxford Immunotec, None:
Research Funding
Shire, Site PI; unpaid consultant: Research Funding
Astellas, Site PI: Research Funding
Chimerix, Site PI: Research Funding
Merck, Site PI: Research Funding
Oxford Immunotec, Site PI: Research Funding
Shire, Site PI; unpaid consultant: Research Funding
Astellas, Site PI: Research Funding
Chimerix, Site PI: Research Funding
Merck, Site PI: Research Funding
Oxford Immunotec, Site PI: Research Funding
Celgene, SAB:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite Pharma, Employee:
Ownership Interest
and
Salary
Kite Pharma, Employee: Financial Benefit and/or patents and Salary
Kite Pharma, Employee: Financial Benefit and/or patents and Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
B
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Study Investigator:
Consultancy
and
Research Funding
Oxis, funding recipient: Research Funding
Zymogen, consultant: Consultancy
Juno, advisory board: Advisory Board
Seattle Genetics, advisory board: Advisory Board
Oxis, funding recipient: Research Funding
Zymogen, consultant: Consultancy
Juno, advisory board: Advisory Board
Seattle Genetics, advisory board: Advisory Board
Seattle Genetics, Member:
Advisory Board
Sanofi, Member: Advisory Board
Sanofi, Member: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
PIRCHE AG, VP Operations & Medical Affairs:
Employed
Merck, research fund:
Research Funding
Seattle genetics, research fund: Research Funding
Celgene, research fund: Research Funding
Jansen, Advisor: Advisory Board
Seattle genetics, research fund: Research Funding
Celgene, research fund: Research Funding
Jansen, Advisor: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Moffitt Cancer Center, Summer student:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Cerus Corp, Employment:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lundbeck, Advisory Board:
Advisory Board
and
Honoraria
Bristol Myers Squibb, Honoraria: Honoraria
Novartis, Speaker: Speaker
Janssen, Speaker: Speaker
Bristol Myers Squibb, Honoraria: Honoraria
Novartis, Speaker: Speaker
Janssen, Speaker: Speaker
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, speakers bureau:
speakers bureau
Takeda, speakers bureau: speakers bureau
Celgene, speakers bureau: speakers bureau
Amgen, Speakers bureau: Speakers bureau
Takeda, speakers bureau: speakers bureau
Celgene, speakers bureau: speakers bureau
Amgen, Speakers bureau: Speakers bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kymab, Ltd, employee:
Intellectual Property Rights
and
Salary
Nothing to Disclose
Nothing to Disclose
Vitae Pharmaceuticals, Inc., Consultant:
Consultancy
Kadmon Corporation, Principal Investigator: Research Funding
Flx Bio, SAB: Advisory Board
Oncoimmunology, SAB: Advisory Board
Five Prime Therapeutics, SAB: Advisory Board
Tmunity, Founder: Ownership Interest
Bluebird Bio, Speaker: Honoraria
Biogen, Speaker: Honoraria
Flx Bio, Advisory Board Attendee: Consultancy
Vitae Pharmaceuticals, Consultant: Consultancy
Five Prime Therapeutics, Advisory Board Attendee: Consultancy
Kymab, Advisory Board Attendee: Consultancy
Bristol-Myers Squibb, Advisory Board Attendee: Consultancy
Fate Therapeutics, Consultant: Consultancy
Merck Serono, Consultant: Consultancy
Merck, Sharpe, & Dohme Corp, Consultant: Consultancy
Sidley Austin LLP, Consultant: Consultancy
Idera Pharma, Consultant: Consultancy
Kadmon Pharmaceuticals, Inc., Investigator/Advisory Board Attendee: Consultancy and Research Funding
Tobria Therapeutics, Ad Hoc/Advisory Board Attendee: Consultancy
Vulcan Capital, Consultant: Consultancy
Kadmon Corporation, Principal Investigator: Research Funding
Flx Bio, SAB: Advisory Board
Oncoimmunology, SAB: Advisory Board
Five Prime Therapeutics, SAB: Advisory Board
Tmunity, Founder: Ownership Interest
Bluebird Bio, Speaker: Honoraria
Biogen, Speaker: Honoraria
Flx Bio, Advisory Board Attendee: Consultancy
Vitae Pharmaceuticals, Consultant: Consultancy
Five Prime Therapeutics, Advisory Board Attendee: Consultancy
Kymab, Advisory Board Attendee: Consultancy
Bristol-Myers Squibb, Advisory Board Attendee: Consultancy
Fate Therapeutics, Consultant: Consultancy
Merck Serono, Consultant: Consultancy
Merck, Sharpe, & Dohme Corp, Consultant: Consultancy
Sidley Austin LLP, Consultant: Consultancy
Idera Pharma, Consultant: Consultancy
Kadmon Pharmaceuticals, Inc., Investigator/Advisory Board Attendee: Consultancy and Research Funding
Tobria Therapeutics, Ad Hoc/Advisory Board Attendee: Consultancy
Vulcan Capital, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, Academic partnership:
Research Funding
Novartis, Academic partnership: Research Funding
Bristol-Myers Squibb, Academic partnership: Research Funding
Constellation Pharmaceuticals, Academic partnership: Research Funding
Millennium, Academic partnership: Research Funding
Janssen, Academic partnership: Research Funding
Morphosys, Academic partnership: Research Funding
National Cancer Institute, Academic partnership: NCI grant â K24CA201524
Novartis, Academic partnership: Research Funding
Bristol-Myers Squibb, Academic partnership: Research Funding
Constellation Pharmaceuticals, Academic partnership: Research Funding
Millennium, Academic partnership: Research Funding
Janssen, Academic partnership: Research Funding
Morphosys, Academic partnership: Research Funding
National Cancer Institute, Academic partnership: NCI grant â K24CA201524
Merck, Consultant:
Advisory Board
Chimerix, site investigator: Research Funding
Chimerix, site investigator: Research Funding
Nothing to Disclose
Nothing to Disclose
Merck Research laboratories, independent investigator:
Consultancy
and
Research Funding
Chimerix Inc, independent investigator: Consultancy and Research Funding
Glaxo Smith Kline, independent investigator: Consultancy and Research Funding
Roche/Genentech, independent investigator: Consultancy and Research Funding
Clinigen, independent investigator: Consultancy
Ansun Biopharma, none: Research Funding
Gilead Sciences, INC, none: Consultancy and Research Funding
GSK, none: Research Funding
Humabs, none: Consultancy
BioMed, none: Consultancy
Merck, none: Consultancy and Research Funding
Aviragen Therapeutics Inc., none: Consultancy
Merck, Consultant; Investigator: Consultancy and Research Funding
Shire, Consultant: Consultancy
Chimerix, Consultant; Investigator: Consultancy and Research Funding
Microbiotix, Consultant: Consultancy
Helocyte, Consultant: Consultancy
Astellas, Consultant; Investigator: Consultancy and Research Funding
Aviragen, none: Consultancy and Research Funding
Astellas, Consultant, site investigator: Consultancy , Honoraria and Research Funding
Merck, Consultant, site investigator: Consultancy , Honoraria and Research Funding
Chimerix, Consultant, site investigator: Consultancy , Honoraria and Research Funding
Helocyte, Consultant: Consultancy and Honoraria
Shire, Consultant: Consultancy and Honoraria
Oxford Immunotec, Consultant: Consultancy and Honoraria
Microbiotix, Consultant: Consultancy and Honoraria
Roche Molecular Systems, Site investigator: Research Funding
Merck, Astellas, Shire, Chimerix, Investigator, Consultant: Honoraria
Microbiotix, Oxford Immunotec, Consultant: Stipend
Chimerix Inc, independent investigator: Consultancy and Research Funding
Glaxo Smith Kline, independent investigator: Consultancy and Research Funding
Roche/Genentech, independent investigator: Consultancy and Research Funding
Clinigen, independent investigator: Consultancy
Ansun Biopharma, none: Research Funding
Gilead Sciences, INC, none: Consultancy and Research Funding
GSK, none: Research Funding
Humabs, none: Consultancy
BioMed, none: Consultancy
Merck, none: Consultancy and Research Funding
Aviragen Therapeutics Inc., none: Consultancy
Merck, Consultant; Investigator: Consultancy and Research Funding
Shire, Consultant: Consultancy
Chimerix, Consultant; Investigator: Consultancy and Research Funding
Microbiotix, Consultant: Consultancy
Helocyte, Consultant: Consultancy
Astellas, Consultant; Investigator: Consultancy and Research Funding
Aviragen, none: Consultancy and Research Funding
Astellas, Consultant, site investigator: Consultancy , Honoraria and Research Funding
Merck, Consultant, site investigator: Consultancy , Honoraria and Research Funding
Chimerix, Consultant, site investigator: Consultancy , Honoraria and Research Funding
Helocyte, Consultant: Consultancy and Honoraria
Shire, Consultant: Consultancy and Honoraria
Oxford Immunotec, Consultant: Consultancy and Honoraria
Microbiotix, Consultant: Consultancy and Honoraria
Roche Molecular Systems, Site investigator: Research Funding
Merck, Astellas, Shire, Chimerix, Investigator, Consultant: Honoraria
Microbiotix, Oxford Immunotec, Consultant: Stipend
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
MolMed, management position:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite Pharma, Employee:
Financial Benefit and/or patents
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz, Meeting Session Chair:
Honoraria
Sanofi, AdBoard, Research Support: Honoraria and Research Funding
Celgene, Adboard: Honoraria
Otsuka, Educational Grant for Meeting Travel: Honoraria
Sanofi, AdBoard, Research Support: Honoraria and Research Funding
Celgene, Adboard: Honoraria
Otsuka, Educational Grant for Meeting Travel: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix, Inc., Executive Director, Biostatistics:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, none:
Funding for educational program
Nothing to Disclose
Nothing to Disclose
Novartis, Consultant:
Consultancy
Nothing to Disclose
Point Guard LLC, Partner:
Ownership Interest
Nothing to Disclose
NIH, NCI, assistant clinical investigator:
Intellectual Property Rights
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
C
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, Speaker:
Honoraria
Novartis, Speaker: Honoraria
Novartis, Speaker: Honoraria
Otsuka, None:
Research Funding
Celgene, Research Funding: Research Funding
Celgene, Research Funding: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Taiho, Advisory Board:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Point Guard LLC, Monitor:
Salary
Seattle Genetics, Study Investigator:
Research Funding
Nothing to Disclose
Spectrum Pharmaceuticals, Advisory Board Member:
Advisory Board
Pfizer, Advisory Board Member: Advisory Board
Pfizer, Advisory Board Member: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Study Investigator:
Research Funding
and
Speakers bureau
Celgene, Speakers' bureau: Speakers' bureau
Gilead, Speaker's bureau: Speaker's bureau
Novartis, Speaker's bureau: Speaker's bureau
Celgene, Speakers' bureau: Speakers' bureau
Gilead, Speaker's bureau: Speaker's bureau
Novartis, Speaker's bureau: Speaker's bureau
Kymab, Ltd, employee:
Intellectual Property Rights
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Infinity, Researcher, advisory:
Consultancy
Celgene, Researcher (PI): Research Funding
Celgene, Researcher (PI): Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte Inc., ad hoc Scientific Advisory Board:
Advisory Board
and
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, investigator:
Research Funding
Sanofi, investigator: Research Funding
Sanofi, investigator: Research Funding
Nothing to Disclose
Merck & Co., Inc., employee:
Salary
Nothing to Disclose
Nothing to Disclose
Oxford Immunotec, None:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
celgene, consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Janssen, Member:
Speaker's Bureau
Nothing to Disclose
Nothing to Disclose
Chimerix, Research funding:
Research Funding
Merck, Research funding: Research Funding
AiCuris, Research fundings: Research Funding
Novartis, Research fundings: Research Funding
Oxford Immunotec, Consulting: Consultancy
Merck, Consulting: Consultancy
Chimerix, Consulting: Consultancy
Astellas, Consulting: Consultancy
Gilead, research grant and consultant: Consultancy and Research Funding
ADMA Biologics, consultant: Consultancy
Merck, Research funding: Research Funding
AiCuris, Research fundings: Research Funding
Novartis, Research fundings: Research Funding
Oxford Immunotec, Consulting: Consultancy
Merck, Consulting: Consultancy
Chimerix, Consulting: Consultancy
Astellas, Consulting: Consultancy
Gilead, research grant and consultant: Consultancy and Research Funding
ADMA Biologics, consultant: Consultancy
Nothing to Disclose
Seattle Genetics, Study Investigator:
Consultancy
and
Research Funding
Genentech, Consultant: Consultancy
Genentech, Consultant: Consultancy
Chih Yu Chen, Statistician:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Advisory Board Speaker and Consultant:
Consulting Fee
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celator, Employee:
Stock options/awards
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix, Inc., Director, Clinical Research:
Ownership Interest
and
Salary
Nothing to Disclose
Bristol Myers Squibb, Ad board member:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis Pharmaceuticals Corporation, Vendor Biostatistician:
Consultancy
and
Providing consultancy services to Novartis representig Numerus Analytics
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Bristol-Meyers Squibb, Consultant:
Consultancy
and
Research Funding
Janssen, Consultant: Consultancy
Janssen, Consultant: Consultancy
Nothing to Disclose
Sanofi Pasteur, CRADA (collaborative research agreement):
Research Funding
3M, stockholder: stockholder
3M, stockholder: stockholder
Bristol-Myers Squibb, Clinical investigator:
Research Funding
Novartis, Clinical investigator: Research Funding
Millennium/Takeda, Clinical investigator: Research Funding
Pharmacyclics, Clinical investigator: Research Funding
Seattle Genetics, Clinical investigator: Research Funding
Infinity, Academic advisor: Advisory Board
Abbvie, Academic advisor: Advisory Board
Celgene, Academic advisor: Advisory Board
Novartis, Academic advisor: Advisory Board
Lymphoma Research Foundation, Grant funding: Research Funding
American society of hematology, Grant funding: Research Funding
Novartis, Clinical investigator: Research Funding
Millennium/Takeda, Clinical investigator: Research Funding
Pharmacyclics, Clinical investigator: Research Funding
Seattle Genetics, Clinical investigator: Research Funding
Infinity, Academic advisor: Advisory Board
Abbvie, Academic advisor: Advisory Board
Celgene, Academic advisor: Advisory Board
Novartis, Academic advisor: Advisory Board
Lymphoma Research Foundation, Grant funding: Research Funding
American society of hematology, Grant funding: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Point Guard LLC, Partner:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
MolMed, Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi Genzyme, Consultant:
Consultancy
Pharmerit, Employee: Salary
Pharmerit, Employee: Salary
Nothing to Disclose
Merck & Co., Inc., Investigator:
Research Funding
Point Guard LLC, Researcher:
Salary
Nothing to Disclose
Ambit BioSciences, Support:
Consultancy
and
Research funding for my institution.
Amphivena Therapeutics, Support: Consultancy
ARIAD, Support: Consultancy and Research funding for my institution.
Astellas Pharma, Support: Consultancy and Research funding for my institution.
Arog Pharmaceuticals, Support: Research funding for my institution.
AstraZeneca, Support: Research funding for my institution.
BiolinRx, Support: Consultancy
Bristol-Myers Squibb, Support: Consultancy and Research funding for my institution.
Celator, Support: Research funding for my institution.
Celgene, Suport: Research funding for my institution.
Novartis, Support: Consultancy and Research funding for my institution.
Pfizer, Support: Consultancy and Research funding for my institution.
Sanofi, Support: Research funding for my institution.
Teva, Support: Research funding for my institution.
Amphivena Therapeutics, Support: Consultancy
ARIAD, Support: Consultancy and Research funding for my institution.
Astellas Pharma, Support: Consultancy and Research funding for my institution.
Arog Pharmaceuticals, Support: Research funding for my institution.
AstraZeneca, Support: Research funding for my institution.
BiolinRx, Support: Consultancy
Bristol-Myers Squibb, Support: Consultancy and Research funding for my institution.
Celator, Support: Research funding for my institution.
Celgene, Suport: Research funding for my institution.
Novartis, Support: Consultancy and Research funding for my institution.
Pfizer, Support: Consultancy and Research funding for my institution.
Sanofi, Support: Research funding for my institution.
Teva, Support: Research funding for my institution.
Nothing to Disclose
Celgene, Self:
Honoraria
Amgen, Self: Honoraria and Research Funding
Sanofi, Self: Consultancy , Honoraria and Research Funding
Amgen, Self: Honoraria and Research Funding
Sanofi, Self: Consultancy , Honoraria and Research Funding
Mayo Hospital, Nurse:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Mallinckrodt, Inc, None:
Research funding
Merck, Inc, None: Consultancy and Honoraria
Merck, Inc, None: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis Pharmaceuticals Corporation, Employee:
Employee
Oxford Immunotec, employee:
Salary
Takeda, Speaker Bureau:
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Regimmune, Investigator/Consultancy/Advisory Role:
Consultancy
Seattle Genetics, Investigator/Consultancy/Advisory Role: Consultancy
Insys, Investigator/Consultancy/Advisory Role: Consultancy
Incyte, Investigator/Consultancy/Advisory Role: Consultancy
Pfizer, Seattle Genetics, Sandoz, Kite, Insys, Pharmacyclics, Advisory Board: Stipend
Seattle Genetics, Investigator/Consultancy/Advisory Role: Consultancy
Insys, Investigator/Consultancy/Advisory Role: Consultancy
Incyte, Investigator/Consultancy/Advisory Role: Consultancy
Pfizer, Seattle Genetics, Sandoz, Kite, Insys, Pharmacyclics, Advisory Board: Stipend
Nothing to Disclose
Nothing to Disclose
D
Nothing to Disclose
Prothena, .:
Institutional Research Funding for clinical trial
Celgene, .: Research Funding
Merck, .: Institutional Research Funding for clinical trial
Celgene, .: Research Funding
Merck, .: Institutional Research Funding for clinical trial
Nothing to Disclose
Nothing to Disclose
Oxford Immunotec, None:
Research Funding
Gilead, None: Research Funding
Merck, None: Research Funding
Ansun Biopharma, None: Research Funding
Gilead, None: Research Funding
Merck, None: Research Funding
Ansun Biopharma, None: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Immunogen, advisor:
Advisory Board
and
Honoraria
Pharmacyclics, advisor: Advisory Board and Honoraria
Presage, consultant: Consultancy
Prime Oncology, Speaker: Honoraria
Takeda, Research: Research Funding
Gilead Sciences, research: Research Funding
Pharmacyclics, advisor: Advisory Board and Honoraria
Presage, consultant: Consultancy
Prime Oncology, Speaker: Honoraria
Takeda, Research: Research Funding
Gilead Sciences, research: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Consultant:
Consultancy
Novartis, Outside consultant: Consultancy
Novartis, Outside consultant: Consultancy
Precision Biosciences, SAB:
Advisory Board
Celyad, Consultant: Consultancy
Adaptive Biotechnologies, Ad Board: Advisory Board
Kite Pharma, Ad Board: Advisory Board
Celyad, Consultant: Consultancy
Adaptive Biotechnologies, Ad Board: Advisory Board
Kite Pharma, Ad Board: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
medac, grantee:
Honoraria
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Amneal Biosciences, Medial Science Liaison:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Dava Oncology, Hemedicus, Genetech, Speaker:
Honoraria
Bristol-Myers-Squibb, Speaker: Support for Travel
Asterias, Amphivena, Bluebird, Attend Advisory Board: Support for Travel
SRA International, IRA, Grant Review: Honoraria
Magenta, Celgene, Bioline, Attend Advisory Meeting: Fee for participation
Rivervest, Attend board meeting: Fee for participation
Cellworks, Consultant: Fee for participation
Magenta, Stockholder: Stockholder
Bristol-Myers-Squibb, Speaker: Support for Travel
Asterias, Amphivena, Bluebird, Attend Advisory Board: Support for Travel
SRA International, IRA, Grant Review: Honoraria
Magenta, Celgene, Bioline, Attend Advisory Meeting: Fee for participation
Rivervest, Attend board meeting: Fee for participation
Cellworks, Consultant: Fee for participation
Magenta, Stockholder: Stockholder
Nothing to Disclose
Nothing to Disclose
Achillion Pharmaceutical, Consultant:
Consultancy
Alexion Pharmaceuticals., Consultant: Consultancy , Research Funding and Speakers Bureau
Alexion Pharmaceuticals., Consultant: Consultancy , Research Funding and Speakers Bureau
Nothing to Disclose
FACT Consulting Services, Senior Consultant:
Consultancy
Jazz Pharmaceuticals, Employee:
Stock options/awards
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi Genzyme, Employee:
Salary
Janssen, none:
Advisory Board
Gilead, none: Advisory Board and Honoraria
Roche, none: Advisory Board
Novartis, none: Advisory Board and Honoraria
Gilead, none: Advisory Board and Honoraria
Roche, none: Advisory Board
Novartis, none: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lentigen Technology, Employee:
Employee
Nothing to Disclose
Merck, Consultant, site investigator, speakers bureau:
Consultancy
,
Honoraria
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Pharmacyclics, LLC, an AbbVie Company, Employee:
Salary
AbbVie, Employee of Pharmacyclics, LLC, an AbbVie Company: Ownership Interest
AbbVie, Employee of Pharmacyclics, LLC, an AbbVie Company: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Ad Board:
Advisory Board
Nothing to Disclose
Nothing to Disclose
E
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Janssen, consultant:
Advisory Board
,
Consultancy
and
Honoraria
Celgene, consultant: Advisory Board , Consultancy and Honoraria
Amgen, consultant: Advisory Board , Consultancy and Honoraria
Novartis, consultant: Advisory Board , Consultancy and Honoraria
Novartis, Consultant: Advisory Board , Consultancy and Honoraria
Amgen, Consultant: Advisory Board , Consultancy and Honoraria
Celgene, Consultant: Advisory Board , Consultancy , Honoraria and Research Funding
Janssen Cilag, Janssen Pharmaceutical, Consultant: Advisory Board , Consultancy , Honoraria and Research Funding
Celgene, Consultant, speakers bureau: Consultancy and Honoraria
Janssen, Consultant, speakers bureau: Consultancy and Honoraria
Amgen, Consultant, speakers bureau: Consultancy and Honoraria
Novartis, Consultant: Consultancy and Honoraria
Merck, Consultant: Advisory Board
Chimerix, Consultant: Consultancy and Honoraria
Celgene, consultant: Advisory Board , Consultancy and Honoraria
Amgen, consultant: Advisory Board , Consultancy and Honoraria
Novartis, consultant: Advisory Board , Consultancy and Honoraria
Novartis, Consultant: Advisory Board , Consultancy and Honoraria
Amgen, Consultant: Advisory Board , Consultancy and Honoraria
Celgene, Consultant: Advisory Board , Consultancy , Honoraria and Research Funding
Janssen Cilag, Janssen Pharmaceutical, Consultant: Advisory Board , Consultancy , Honoraria and Research Funding
Celgene, Consultant, speakers bureau: Consultancy and Honoraria
Janssen, Consultant, speakers bureau: Consultancy and Honoraria
Amgen, Consultant, speakers bureau: Consultancy and Honoraria
Novartis, Consultant: Consultancy and Honoraria
Merck, Consultant: Advisory Board
Chimerix, Consultant: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite Pharma, Employee:
Ownership Interest
and
Salary
Kite Pharma, Employee: Financial Benefit and/or patents and Salary
Kite Pharma, Employee: Financial Benefit and/or patents and Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pfizer, none:
Consultancy
Gilead Sciences, INC, none: Consultancy and Research Funding
GlaxoSmithKline, none: Research Funding
MedImmune, none: Research Funding
Allios, none: Research Funding
Gilead Sciences, INC, none: Consultancy and Research Funding
GlaxoSmithKline, none: Research Funding
MedImmune, none: Research Funding
Allios, none: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
F
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Takeda, speaker:
speakers bureau
Celgene, speaker: speakers bureau
Celgene, speaker: speakers bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite Pharma, Recipient:
Research Funding
Nothing to Disclose
NIH, NCI, contractor:
Intellectual Property Rights
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, Consultant:
Consultancy
and
Honoraria
Sanofi, Consultant: Consultancy and Honoraria
Pharmacyclics, Consultant: Consultancy and Honoraria
Seattle Genetics, Consultant: Consultancy and Honoraria
Sanofi, Consultant: Consultancy and Honoraria
Pharmacyclics, Consultant: Consultancy and Honoraria
Seattle Genetics, Consultant: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
GVHD Biomarker patent, Intellectual property:
Intellectual Property Rights
and
Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pharmacyclics, LLC, an AbbVie Company, Investigator:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi, speaker bureau:
Consultancy
and
Honoraria
Teva, consultant: Consultancy and Honoraria
Amgen, speaker bureau: Consultancy and Honoraria
Teva, consultant: Consultancy and Honoraria
Amgen, speaker bureau: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
abbvie, consultant:
Consultancy
Genentech, consultancy: Consultancy
Pharmacyclics, consultancy: Consultancy
Janssen, consultancy: Consultancy
Genentech, consultancy: Consultancy
Pharmacyclics, consultancy: Consultancy
Janssen, consultancy: Consultancy
UCB, consultant:
Consultancy
Roche, consultant: Consultancy
Pfizer, consultant: Consultancy
Novartis, consultant: Consultancy
Genentech, consultant: Consultancy and Research Funding
CORRONNA, consultant: Consultancy
Bristol Myers Squibb, consultant: Consultancy and Research Funding
Amgen, consultant: Consultancy and Research Funding
Actelion, consultant: Consultancy
Abbvie, consultant: Consultancy
Roche, consultant: Consultancy
Pfizer, consultant: Consultancy
Novartis, consultant: Consultancy
Genentech, consultant: Consultancy and Research Funding
CORRONNA, consultant: Consultancy
Bristol Myers Squibb, consultant: Consultancy and Research Funding
Amgen, consultant: Consultancy and Research Funding
Actelion, consultant: Consultancy
Abbvie, consultant: Consultancy
Nothing to Disclose
G
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Bristol-Myers Squibb, Medical Scientist:
Salary
Gamida Cell Ltd., Employee:
Employment
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Study Investigator:
Research Funding
Amgen, Speaker: Honoraria
Janssen, Speaker: Honoraria and Travel expenses
MSD, Speaker: Honoraria
Takeda, Speaker: Honoraria and Travel expenses
Hospira (Pfizer), Researcher: Research Funding
Amgen, Speaker: Honoraria
Janssen, Speaker: Honoraria and Travel expenses
MSD, Speaker: Honoraria
Takeda, Speaker: Honoraria and Travel expenses
Hospira (Pfizer), Researcher: Research Funding
Nothing to Disclose
Nothing to Disclose
Novartis, consultant:
Consultancy
and
Research Funding
Bioinvent, member: Research Funding
Medimmune, consultant: Consultancy
Bioinvent, member: Research Funding
Medimmune, consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
celgene, conultant:
Advisory Board
,
Consultancy
and
Research Funding
janssen, consutant: Consultancy
takeda, consultant: Consultancy
janssen, consutant: Consultancy
takeda, consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, None:
Research Funding
Nothing to Disclose
Provenance Biopharmaceuticals, Employee:
Financial Benefit and/or patents
and
Salary
Nothing to Disclose
Nothing to Disclose
Celgene, Takeda, Amgen, Speaker:
Advisory Board
Jazz, Sanofi, Speaker: Compensation
Jazz, Sanofi, Speaker: Compensation
Nothing to Disclose
Neovii, Vice President Neovii Biotech North America:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite Pharma, Employee:
Ownership Interest
and
Salary
Kite Pharma, Employee: Financial Benefit and/or patents and Salary
Kite Pharma, Employee: Financial Benefit and/or patents and Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
AMGEN, speaker/advisory:
Advisory Board
and
Honoraria
CELGENE, speaker/advisory: Advisory Board and Honoraria
PFIZER, speaker/advisory: Advisory Board and Honoraria
BRISTOL, speaker/advisory: Advisory Board and Honoraria
JANSSEN, speaker/advisory: Advisory Board and Honoraria
AMGEN, speaker/advisory board: Advisory Board
Bristol, speaker/advisory board: Advisory Board
Pfizer, speaker/advisory board: Advisory Board
Celgene, speaker/advisory board: Advisory Board
Janssen, speaker/advisory board: Advisory Board
CELGENE, speaker/advisory: Advisory Board and Honoraria
PFIZER, speaker/advisory: Advisory Board and Honoraria
BRISTOL, speaker/advisory: Advisory Board and Honoraria
JANSSEN, speaker/advisory: Advisory Board and Honoraria
AMGEN, speaker/advisory board: Advisory Board
Bristol, speaker/advisory board: Advisory Board
Pfizer, speaker/advisory board: Advisory Board
Celgene, speaker/advisory board: Advisory Board
Janssen, speaker/advisory board: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gamida Cell, Employee:
Employment
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Advisory Council:
Advisory Board
and
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
NIH, NCI, ETIB, branch chief:
Intellectual Property Rights
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix, Inc., None:
Advisory Board
and
Investigator
Nothing to Disclose
Nothing to Disclose
Fresinius, contracted to perfrom study:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz, Consultant:
Advisory Board
and
Consultancy
Janssen, Consultant: Advisory Board and Consultancy
Pfizer, Consultant: Advisory Board and Consultancy
Novartis, Consultant: Advisory Board , Consultancy and Research Funding
Jazz Pharmaceuticals, Support: Consultancy
Novartis, consultant: Consultancy , Honoraria and Research Funding
Janssen, Consultant: Advisory Board and Consultancy
Pfizer, Consultant: Advisory Board and Consultancy
Novartis, Consultant: Advisory Board , Consultancy and Research Funding
Jazz Pharmaceuticals, Support: Consultancy
Novartis, consultant: Consultancy , Honoraria and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Incyte, Speaker, Advisory Board, Research Funding:
Honoraria
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, Employed:
Equity Ownership
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
H
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
CSL-Behring, None:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, NA:
Ownership Interest
NIH, NA: Research Funding
NIH, NA: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Support:
Consultancy
Nothing to Disclose
Nothing to Disclose
Cerus Corporation, employee:
Salary
and
Stockholder
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi, consultant:
Consultancy
Sanofi, consultant: Consultancy and Honoraria
Sanofi, consultant: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, None:
Research Funding
Cell Medica, None: Research Funding and Royalty
Viracyte, Founder: Ownership Interest
Chimerix, None: Advisory Board
Viracyte, Co-founder: Ownership Interest
Marker Therapeutics, Co-Founder: Ownership Interest
Cell Medica, None: Advisory Board and Intellectual Property Rights
Celgene, none: Research Funding
Cell Medica, None: Research Funding and Royalty
Viracyte, Founder: Ownership Interest
Chimerix, None: Advisory Board
Viracyte, Co-founder: Ownership Interest
Marker Therapeutics, Co-Founder: Ownership Interest
Cell Medica, None: Advisory Board and Intellectual Property Rights
Celgene, none: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix Inc., investigator-initiated grant:
Research Funding
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nippon Shinyaku, speaking and teaching:
Consultancy
and
Honoraria
Phizer, speaking and teaching, independent contractor: Honoraria and Research Funding
Alexion, speaking and teaching, independent contractor: Honoraria and Research Funding
Phizer, speaking and teaching, independent contractor: Honoraria and Research Funding
Alexion, speaking and teaching, independent contractor: Honoraria and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi, Support:
Consultancy
Roche, Support: Travel, Accomodations, and Expenses
Roche, Support: Travel, Accomodations, and Expenses
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pharmacyclics, chronic GvHD:
Advisory Board
Prime Oncology, Educational activity in acute GvHD: Honoraria
Sanofi, Satellite symposium on acute GvHD: Honoraria
Prime Oncology, Educational activity in acute GvHD: Honoraria
Sanofi, Satellite symposium on acute GvHD: Honoraria
Seattle Genetics, Research Funding:
Consult/Advisory
and
Research Funding
Merck, Research Funding: Research Funding
Millennium, Research Funding: Research Funding
Sanofi, Research Funding: Research Funding
Merck, Research Funding: Research Funding
Millennium, Research Funding: Research Funding
Sanofi, Research Funding: Research Funding
Alexion, Investigator:
Site principal investigator on GI GVHD clinical trial
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pluristem Therapeutics, Inc, Advisory Board:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Biogen, PI of a PhD student sponsored by Biogen:
Research Funding
St. Baldrick's Foundation, Scientific Advisory Committee: Advisory Board
St. Baldrick's Foundation, Scientific Advisory Committee: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz, consultant:
Consultancy
Takeda Pharmaceuticals Co., Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Employee:
Stock options/awards
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck & Co., Inc., employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
I
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
J
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite Pharma, Member:
Advisory Board
Nothing to Disclose
Merk, advisor:
Advisory Board
Celgene, ad board: Advisory Board
BMS, ad board: Advisory Board
Novartis, ad board: Advisory Board
Celgene, ad board: Advisory Board
BMS, ad board: Advisory Board
Novartis, ad board: Advisory Board
Theracos, Investigator/Consultancy/Advisory Role:
Consultancy
and
Research Funding
Janssen, Investigator/Consultancy/Advisory Role: Consultancy and Research Funding
Janssen, Investigator/Consultancy/Advisory Role: Consultancy and Research Funding
Pharmacyclics, LLC, an AbbVie Company, Investigator/Consultancy/Advisory Role:
Consultancy
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pharmacyclics, LLC, an AbbVie Company, Employee:
Salary
AbbVie, Employee of Pharmacyclics, LLC, an AbbVie Company: Ownership Interest
AbbVie, Employee of Pharmacyclics, LLC, an AbbVie Company: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz, consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite Pharma, Employee:
Ownership Interest
and
Salary
Kite Pharma, Employee: Financial Benefit and/or patents and Salary
Kite Pharma, Employee: Financial Benefit and/or patents and Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Patent pending, Applicant:
Intellectual Property Rights
Alexion, Invited speaker: Honoraria
Novartis, Consultancy: Consultancy
Alexion, Invited speaker: Honoraria
Novartis, Consultancy: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novimmune, Scientific advisory board:
Consultancy
and
Honoraria
roche, consultant: Consultancy
roche, consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, None:
Intellectual Property Rights
and
Research Funding
Nothing to Disclose
Nothing to Disclose
K
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Miltenyi Biotec, employee:
Salary
Nothing to Disclose
ViraCyte LLC, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck & Co., Inc., employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kymab, Ltd:
Intellectual Property Rights
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis Pharmaceuticals Corporation, Medical Director:
Employee
InSightRx, Co-founder and CSO:
Financial Benefit and/or patents
,
Intellectual Property Rights
,
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, None:
Financial Benefit and/or patents
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Omeros, Clinical PI:
Research Funding
Daichii, Consultant: Consultancy
Alexion, Consultant: Consultancy and Honoraria
Omeros, none: Research Funding
Daichii, none: Consultancy
Alexion, none: Consultancy and Honoraria
Daichii, Consultant: Consultancy
Alexion, Consultant: Consultancy and Honoraria
Omeros, none: Research Funding
Daichii, none: Consultancy
Alexion, none: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte Corp, Speaker Bureau:
Speaker Bureau
Seattle Genetics, Speaker Bureau: Speaker Bureau
Seattle Genetics, Speaker Bureau: Speaker Bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celltrion, none:
Honoraria
and
Research Funding
Gilead Sciences, INC, none: Consultancy and Research Funding
SK chemicals, none: Research Funding
Janssen, none: Honoraria
Gilead Sciences, INC, none: Consultancy and Research Funding
SK chemicals, none: Research Funding
Janssen, none: Honoraria
Nothing to Disclose
Nothing to Disclose
Spectrum Pharmaceuticals, Consultant:
Advisory Board
Johnson and Johnson, Husband is financial analyst: Salary
Johnson and Johnson, Husband is financial analyst: Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kymab, Ltd, employee:
Intellectual Property Rights
and
Salary
Takeda Pharmaceutical, Speaker's Bureau:
Honoraria
Nothing to Disclose
Mallinckrodt, Speaker:
Honoraria
Novartis, Advisory Board: Advisory Board and Honoraria
Novartis, Advisory Board: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite Pharma Inc., None:
Research Funding
bluebird bio, None: Research Funding and Royalty
bluebird bio, None: Research Funding and Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Phizer, consulting:
Consultancy
and
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead Sciences, Support:
Consultancy
Pharmacyclics, Support: Consultancy
Seattle Genetics, Support: Consultancy
Pharmacyclics, Support: Consultancy
Seattle Genetics, Support: Consultancy
Nothing to Disclose
City of Hope Cancer Center, Data Monitoring Committee Member:
Consultancy
Adienne, Data Monitoring Committee Member: Consultancy
Novartis, Data Monitoring Committee Member: Consultancy
Spectrum, Advisor: Advisory Board
KITE Pharma, Scientific Advisor: Advisory Board
Novartis, DSMB Chair: DSMB Member
Adienne, Data Monitoring Committee Member: Consultancy
Novartis, Data Monitoring Committee Member: Consultancy
Spectrum, Advisor: Advisory Board
KITE Pharma, Scientific Advisor: Advisory Board
Novartis, DSMB Chair: DSMB Member
Nothing to Disclose
Nothing to Disclose
Merck, Speaker:
Advisory Board
and
Honoraria
Pfizer, Speaker: Honoraria
Astellas, Speaker: Honoraria
Pfizer, Speaker: Honoraria
Astellas, Speaker: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Prometheus Labs, Consultant:
Research Funding
Millennium Pharmaceuticals, Consultant: Research Funding
Amgen Inc, Consultant: Advisory Board
Kadmon Corp, Consultant: Advisory Board
Takeda Pharmaceuticals, Consultant: Advisory Board
Amgen Inc, Consultant: Consultancy
Millennium Pharmaceuticals, Consultant: Research Funding
Amgen Inc, Consultant: Advisory Board
Kadmon Corp, Consultant: Advisory Board
Takeda Pharmaceuticals, Consultant: Advisory Board
Amgen Inc, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
celgene, consultant:
Advisory Board
,
Consultancy
,
Honoraria
and
Research Funding
janssen, consultant: Consultancy and Honoraria
takeda, consultant: Advisory Board , Consultancy and Honoraria
onyx, consultant: Advisory Board , Consultancy and Honoraria
janssen, consultant: Consultancy and Honoraria
takeda, consultant: Advisory Board , Consultancy and Honoraria
onyx, consultant: Advisory Board , Consultancy and Honoraria
Nothing to Disclose
Novartis, Neovii, Speaker:
Research Grant
Nothing to Disclose
Takeda, speaker and consultant:
Consultancy
Millenium, speaker and consultant: Consultancy
Takena, Consulting: Consultancy
Millennium, Consulting/Speaking: Consultancy
Millenium, speaker and consultant: Consultancy
Takena, Consulting: Consultancy
Millennium, Consulting/Speaking: Consultancy
Nothing to Disclose
Nothing to Disclose
gadetta, founder and shareholder:
Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Oxford Immunotec, None:
Research Funding
Qiagen, None: Consultancy
Astellas, None: Honoraria
Qiagen, None: Consultancy
Astellas, None: Honoraria
Nothing to Disclose
Nothing to Disclose
Celgene, Takeda, Janssen, Sanofi, Abbvie, Novartis, Merck, Consulting:
Research Funding to Mayo
Skyline DX, Consulting: Honoraria
Janssen, Amgen, Takeda, Abbvie, Consulting: None
Skyline DX, Consulting: Honoraria
Janssen, Amgen, Takeda, Abbvie, Consulting: None
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
nil, nil:
nil
L
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, None:
Financial Benefit and/or patents
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Infinity, Stock or Other Ownership:
Ownership Interest
Clovis, Stock or Other Ownership: Ownership Interest
Reviva Pharmaceuticals, Stock or Other Ownership: Ownership Interest
Gilead Sciences, Employee: Ownership Interest and Salary
The Permanente Medical Group, Employee: Ownership Interest and Salary
Pharmacyclics, LLC, an AbbVie Company, Employee: Salary
AbbVie, Employee of Pharmacyclics, LLC, an AbbVie Company: Ownership Interest
Clovis, Stock or Other Ownership: Ownership Interest
Reviva Pharmaceuticals, Stock or Other Ownership: Ownership Interest
Gilead Sciences, Employee: Ownership Interest and Salary
The Permanente Medical Group, Employee: Ownership Interest and Salary
Pharmacyclics, LLC, an AbbVie Company, Employee: Salary
AbbVie, Employee of Pharmacyclics, LLC, an AbbVie Company: Ownership Interest
Nothing to Disclose
Nothing to Disclose
MolMed, management position:
Salary
Nothing to Disclose
Nothing to Disclose
Novartis, Support:
Consultancy
Karyopharm Therapeutics, Support: Consultancy
KaloBios, Support: Consultancy
Celator, Support: Consultancy
Boehringer Ingelheim, Support: Consultancy
Baxalta, Support: Consultancy
Asterios Biotherapeutics, Support: Consultancy
Amgen, Support: Consultancy
Celgene, Support: Consultancy and Research funding for my institution.
Shire, Support: Consultancy
BioSight, Celgene, Erytech, Novartis, Janssen, Bavalta, BioPath Holdings, Daiichi-Sankyo, Consultant: Consulting Fee
BioSight, Celgene, Erytech, Novartis, Janssen, Baxalta, BioPath Holdings, Daiichi-Sankyo, Consultant: Consulting Fee
Karyopharm Therapeutics, Support: Consultancy
KaloBios, Support: Consultancy
Celator, Support: Consultancy
Boehringer Ingelheim, Support: Consultancy
Baxalta, Support: Consultancy
Asterios Biotherapeutics, Support: Consultancy
Amgen, Support: Consultancy
Celgene, Support: Consultancy and Research funding for my institution.
Shire, Support: Consultancy
BioSight, Celgene, Erytech, Novartis, Janssen, Bavalta, BioPath Holdings, Daiichi-Sankyo, Consultant: Consulting Fee
BioSight, Celgene, Erytech, Novartis, Janssen, Baxalta, BioPath Holdings, Daiichi-Sankyo, Consultant: Consulting Fee
Nothing to Disclose
Spectrum Pharmaceuticals, Self:
Advisory Board
and
Honoraria
Janssen, Self: Consultancy
Prothena, Self: Advisory Board and Honoraria
Takeda, Self: Advisory Board and Research Funding
Onyx/Amgen, Self: Research Funding
Janssen, Self: Consultancy
Prothena, Self: Advisory Board and Honoraria
Takeda, Self: Advisory Board and Research Funding
Onyx/Amgen, Self: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Shire, PI on clinical trial:
Research Funding
Chimerix, PI on clinical trial: Research Funding
Astellas, PI on clinical trial: Research Funding
Merck, PI on clinical trial: Research Funding
Chimerix, PI on clinical trial: Research Funding
Astellas, PI on clinical trial: Research Funding
Merck, PI on clinical trial: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Astellas, Speaker:
Advisory Board
and
Honoraria
Nothing to Disclose
Seattle Genetics, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Bristol-Myers Squibb, Advisory board:
Advisory Board
Alexion Pharmaceuticals, Royalty for research:
Financial Benefit and/or patents
and
Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, speaker:
Honoraria
Takeda, speaker: Honoraria
Bristol Myers Squibb, speaker: Honoraria
Janssen, speaker: Honoraria
Jazz Pharmaceuticals, consultant: Consultancy
Seattle Genetics, consultant and speaker: Consultancy and Honoraria
Takeda, speaker: Honoraria
Bristol Myers Squibb, speaker: Honoraria
Janssen, speaker: Honoraria
Jazz Pharmaceuticals, consultant: Consultancy
Seattle Genetics, consultant and speaker: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck, Employee:
Salary
Nothing to Disclose
Flatiron, Consulting:
Consultancy
Epi-Q/Janssen, Consultant: Consultancy
Pfizer, One Time Consultant: Consultancy
Celgene, Speaker (unbranded content): Honoraria
Epi-Q/Janssen, Consultant: Consultancy
Pfizer, One Time Consultant: Consultancy
Celgene, Speaker (unbranded content): Honoraria
Ziopharm Oncology, Inc, Consultant:
Consultancy
Intellia Therapeutics, Inc, Consultant: Consultancy
Jazz Pharmaceuticals, Inc, Consultant: Consultancy
Shire US, Inc, Advisory Board: Advisory Board
Cyto-Sen Therapeutics, Inc, Owner, Founder, Board of Directors: Ownership Interest and Stock
medac Pharma, Advisory board: Advisory Board
Intellia Therapeutics, Inc, Consultant: Consultancy
Jazz Pharmaceuticals, Inc, Consultant: Consultancy
Shire US, Inc, Advisory Board: Advisory Board
Cyto-Sen Therapeutics, Inc, Owner, Founder, Board of Directors: Ownership Interest and Stock
medac Pharma, Advisory board: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Amgen, Advisory Board:
Consultancy
Mallinckrodt, Meeting Speaker: Honoraria
Mallinckrodt, Meeting Speaker: Honoraria
Nothing to Disclose
ViraCyte LLC, Equity Ownership and Patents & Royalties:
Ownership Interest
and
Royalty
Marker LLC, Equity Ownership and Patents: Ownership Interest
Marker LLC, Equity Ownership and Patents: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Sidney Kimmel Cancer Center; Thomas Jefferson University, Core Grant (5P30CA056036-17), Associate Professor and Division Head, Biostatistics, Department of Pharmacology & Experimental Therapeutics:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sarah Cannon, Senior Vice President:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
ProNAI, consultant:
Consultancy
Seattle Genetics, consultant: Consultancy
Medimmume, consultant: Consultancy
Biotest, consultant: Consultancy
Pfizer, consultant: Consultancy
Celgene, consultant: Consultancy
Gilead, consultant: Consultancy
Novartis, consultant: Consultancy
Boehringer Ingelheim, consultant: Consultancy
, Eisai, consultant: Consultancy
Teva, consulting: Consultancy
ADC Therapeutics, consulting: Consultancy
Hopira, consulting: Consultancy
Bayer Juno, consulting: Consultancy
Abbvie, consulting: Consultancy
Regeneron, consulting: Consultancy
Mirati, consulting: Consultancy
Seattle Genetics, consultant: Consultancy
Medimmume, consultant: Consultancy
Biotest, consultant: Consultancy
Pfizer, consultant: Consultancy
Celgene, consultant: Consultancy
Gilead, consultant: Consultancy
Novartis, consultant: Consultancy
Boehringer Ingelheim, consultant: Consultancy
, Eisai, consultant: Consultancy
Teva, consulting: Consultancy
ADC Therapeutics, consulting: Consultancy
Hopira, consulting: Consultancy
Bayer Juno, consulting: Consultancy
Abbvie, consulting: Consultancy
Regeneron, consulting: Consultancy
Mirati, consulting: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead, none:
spouse is employee
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Consultant:
Consultancy
GVHD biomarkers, Co-inventor: Intellectual Property Rights
Therakos, DSMC member: Consultancy
Seattke Genetics, Consultant: Consultancy
GVHD Biomarker patent, Intellectual property: Intellectual Property Rights and Royalty
GVHD biomarkers, Co-inventor: Intellectual Property Rights
Therakos, DSMC member: Consultancy
Seattke Genetics, Consultant: Consultancy
GVHD Biomarker patent, Intellectual property: Intellectual Property Rights and Royalty
Capricor Therapeutics, Consultant:
Consultancy
OccuRx, None: Research Funding
Allergan, Consultant: Consultancy
OccuRx, None: Research Funding
Allergan, Consultant: Consultancy
Kite Pharma, Consultant:
Consultancy
Five Prime, Consultant: Consultancy
BeiGene, Consultant: Consultancy
Innate Pharma, Consultant: Consultancy
Immune Design, Consultant: Consultancy
Corvus, Consultant: Consultancy
Bristol-Myers Squibb, Recipient: Research Funding
Dynavax, Recipient: Research Funding
Pharmacyclics, Recipient: Research Funding
Pfizer, Recipient: Research Funding
Merck, Recipient: Financial Benefit and/or patents
Five Prime, Consultant: Consultancy
BeiGene, Consultant: Consultancy
Innate Pharma, Consultant: Consultancy
Immune Design, Consultant: Consultancy
Corvus, Consultant: Consultancy
Bristol-Myers Squibb, Recipient: Research Funding
Dynavax, Recipient: Research Funding
Pharmacyclics, Recipient: Research Funding
Pfizer, Recipient: Research Funding
Merck, Recipient: Financial Benefit and/or patents
Amgen, advisor:
Advisory Board
and
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Moffitt Cancer Center, Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Pharmacyclics, LLC, an AbbVie Company, Employee:
Salary
AbbVie, Employee of Pharmacyclics, LLC, an AbbVie Company: Ownership Interest
AbbVie, Employee of Pharmacyclics, LLC, an AbbVie Company: Ownership Interest
Jazz Pharmaceuticals, Employee:
Stock options/awards
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Cerus Corporation, Statistician:
Salary
Nothing to Disclose
Mayo Clinic, Employee:
Employment
Janssen, Recipient: Research Funding
Janssen, Recipient: Research Funding
Nothing to Disclose
Chimerix, medical consultancy:
Consultancy
Chimerix, medical consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
NIH, NINDS, physicist:
Intellectual Property Rights
Oxford Immunotec, None:
Consultancy
and
Research Funding
AiCuris, None: Consultancy
Astellas, Site Investigator: Research Funding
AiCuris, Member: Advisory Board
Merck, Site Investigator: Research Funding
Oxford Immunotec, Site Investigator, Consultant: Consultancy and Research Funding
AiCuris, None: Consultancy
Astellas, Site Investigator: Research Funding
AiCuris, Member: Advisory Board
Merck, Site Investigator: Research Funding
Oxford Immunotec, Site Investigator, Consultant: Consultancy and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite Pharma, Member:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Amgen, Investigator/Consultancy/Advisory Role:
Consultancy
Jazz, Investigator/Consultancy/Advisory Role: Consultancy
Pharmacyclics, LLC, an AbbVie Company, Investigator/Consultancy/Advisory Role: Consultancy and Research Funding
Astellas, Investigator: Research Funding
Novartis, Investigator/Consultancy/Advisory Role: Research Funding
Jazz, Investigator/Consultancy/Advisory Role: Consultancy
Pharmacyclics, LLC, an AbbVie Company, Investigator/Consultancy/Advisory Role: Consultancy and Research Funding
Astellas, Investigator: Research Funding
Novartis, Investigator/Consultancy/Advisory Role: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
InSightRx, Scientific Advisor:
scientific advisor
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celator, Employee:
Stock options/awards
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
M
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Consultant for 1/2 day:
Consultancy
Baxalta Immunology, Consultant for 2 hours: Consultancy
Baxalta Immunology, Consultant for 2 hours: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Amgen, Consultant:
Consultancy
Astellas, Consultant, Speakers bureau: Consultancy and Honoraria
Merck, Consultant, site investigator: Consultancy , Honoraria and Research Funding
Pfizer, Consultant, site investigator: Consultancy , Honoraria and Research Funding
Gilead, Consultant, speakers bureau: Consultancy and Honoraria
Shire, Consultant, speakers bureau: Consultancy and Honoraria
Astellas, Consultant, Speakers bureau: Consultancy and Honoraria
Merck, Consultant, site investigator: Consultancy , Honoraria and Research Funding
Pfizer, Consultant, site investigator: Consultancy , Honoraria and Research Funding
Gilead, Consultant, speakers bureau: Consultancy and Honoraria
Shire, Consultant, speakers bureau: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
NIH, NCI, cancer research training award post-baccalaureate:
Intellectual Property Rights
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Moffitt Cancer Center, Researcher:
Salary
Nothing to Disclose
Nothing to Disclose
Anthem Inc, Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Speaker:
Speakers bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, speakers bureau and consulting:
Advisory Board
,
Consultancy
and
Honoraria
Takeda, Speaker's bureau and consulting: Advisory Board , Consultancy and Honoraria
Amgen, Consulting and Speaker's bureau: Consultancy and Honoraria
BMS, Speaker's bureau: Honoraria
Takeda, Speaker's bureau and consulting: Advisory Board , Consultancy and Honoraria
Amgen, Consulting and Speaker's bureau: Consultancy and Honoraria
BMS, Speaker's bureau: Honoraria
Nothing to Disclose
Amgen, Advisory:
Advisory Board
and
Consultancy
Pfizer, Advisory: Advisory Board and Consultancy
Basilea, Advisory: Advisory Board and Consultancy
Amgen, Pfizer, Consultant, Speaker, Ad Board: Stipend
Celgene, Research involvement: No financial transaction
Pfizer, Advisory: Advisory Board and Consultancy
Basilea, Advisory: Advisory Board and Consultancy
Amgen, Pfizer, Consultant, Speaker, Ad Board: Stipend
Celgene, Research involvement: No financial transaction
Chimerix, Inc., None:
Investigator
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
RegImmune, Investigator:
Research Funding
Fresenius, Investigator: Research Funding
Enlivex Therapeutics, Consultant: Consultancy
Pfizer, DSMB Member: DSMB Member
Huron Consulting, Consultant: Consultancy
Janssen, Consultant: Consultancy
Fresenius, Investigator: Research Funding
Enlivex Therapeutics, Consultant: Consultancy
Pfizer, DSMB Member: DSMB Member
Huron Consulting, Consultant: Consultancy
Janssen, Consultant: Consultancy
Jazz Pharmaceuticals, One time discussion panel:
One time discussion panel
Novartis, Support of clinical trials: Support of clinical trials
Novartis, Institutional PI: Research Funding
Gentium, Institutional PI: Advisory Board and Research Funding
Novartis, Support of clinical trials: Support of clinical trials
Novartis, Institutional PI: Research Funding
Gentium, Institutional PI: Advisory Board and Research Funding
Teva, clinical trials:
Research Funding
celgene, consulting: Consultancy
Novartis, consulting: Consultancy
Gilead, consulting: Consultancy and travel
Acerta, consulting: Consultancy
Janssen, consulting: Consultancy , Honoraria and travel
celgene, consulting: Consultancy
Novartis, consulting: Consultancy
Gilead, consulting: Consultancy and travel
Acerta, consulting: Consultancy
Janssen, consulting: Consultancy , Honoraria and travel
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Alexion, Consultant (DSMB member):
Honoraria
Astellas, Site investigator: Research Funding
Chimerix, Site investigator, consultant: Honoraria and Research Funding
LFB, Consultant: Honoraria
Merck, Site investigator, consultant: Honoraria and Research Funding
Roche Molecular Diagnostics, Consultant: Honoraria
Shire, Site investigator, consultant: Honoraria and Research Funding
Astellas, Site investigator: Research Funding
Chimerix, Site investigator, consultant: Honoraria and Research Funding
LFB, Consultant: Honoraria
Merck, Site investigator, consultant: Honoraria and Research Funding
Roche Molecular Diagnostics, Consultant: Honoraria
Shire, Site investigator, consultant: Honoraria and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Study Investigator:
Research Funding
and
Speakers' bureau
Celgene, Consultant: Consultancy and Speaker's bureau
Celgene, Consultant: Consultancy and Speaker's bureau
Nothing to Disclose
Nothing to Disclose
Bayer, none:
Research Funding
Boehringer-Ingelheim, none: Research Funding
Cytori, none: Research Funding
Corbus, none: Research Funding
Roche/Genentech, none: Research Funding
EMD Serono, none: Research Funding
Cytori, none: Advisory Board
Boehringer-Ingelheim, none: Advisory Board
Actelion, none: Grant Review Panel
Boehringer-Ingelheim, none: Research Funding
Cytori, none: Research Funding
Corbus, none: Research Funding
Roche/Genentech, none: Research Funding
EMD Serono, none: Research Funding
Cytori, none: Advisory Board
Boehringer-Ingelheim, none: Advisory Board
Actelion, none: Grant Review Panel
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi, Grant:
Research Funding
Sanofi Genzyme, Funding/Grant received:
Research Funding
Nothing to Disclose
Almac Diagnostics, solid tumor molecular diagnostics which is not directly or indirectly related to the research presented in this poster:
Consultancy
Sanofi, NA:
Advisory Board
and
Honoraria
Celgene, NA: Advisory Board , Honoraria and Research Funding
Janssen, NA: Advisory Board and Honoraria
Onyx, NA: Advisory Board and Honoraria
Bristol Myers Squibb, NA: Advisory Board and Honoraria
The Binding Site, NA: Advisory Board and Honoraria
Karyopharm, NA: Advisory Board and Honoraria
Gamida Cell, NA: Advisory Board and Honoraria
Celgene, NA: Advisory Board , Honoraria and Research Funding
Janssen, NA: Advisory Board and Honoraria
Onyx, NA: Advisory Board and Honoraria
Bristol Myers Squibb, NA: Advisory Board and Honoraria
The Binding Site, NA: Advisory Board and Honoraria
Karyopharm, NA: Advisory Board and Honoraria
Gamida Cell, NA: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Astellas Pharma US, Advisory Board:
Advisory Board
Nothing to Disclose
Honor health, Nurse:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Gamida, Fate, Contracted Research:
Research Funding
Intima, Erytech, National Cord Blood Program, Consulting / Review Panel: Unpaid
Intima, Erytech, National Cord Blood Program, Consulting / Review Panel: Unpaid
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
NIH, PCORI, Site PI:
Research Funding
Colorado Blood Center, Partner: Salary
Actinium Pharmaceuticals, consultant: Consultancy
Fred Hutchinson Cancer Research Center, former employee: Royalty
Colorado Blood Center, Partner: Salary
Actinium Pharmaceuticals, consultant: Consultancy
Fred Hutchinson Cancer Research Center, former employee: Royalty
Nothing to Disclose
Nothing to Disclose
Angios, Support:
Consultancy
and
Research Funding
Amgen, Support: Consultancy
ARIAD, Support: Consultancy
Celgene, Support: Consultancy , Research Funding and Travel, Accomodations, and Expenses
Novartis, Support: Consultancy and Research Funding
Pfizer, Support: Consultancy
Roche/Genentech, Support: Consultancy and Research Funding
MEI Pharma, Support: Research Funding
Merck/Schering Plough, Support: Research Funding
Celator, Support: Research Funding and Travel, Accomodations, and Expenses
Amgen, Support: Consultancy
ARIAD, Support: Consultancy
Celgene, Support: Consultancy , Research Funding and Travel, Accomodations, and Expenses
Novartis, Support: Consultancy and Research Funding
Pfizer, Support: Consultancy
Roche/Genentech, Support: Consultancy and Research Funding
MEI Pharma, Support: Research Funding
Merck/Schering Plough, Support: Research Funding
Celator, Support: Research Funding and Travel, Accomodations, and Expenses
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, None:
Financial Benefit and/or patents
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
NIH, NINDS, contractor:
Intellectual Property Rights
Nothing to Disclose
Novartis, Consultant:
Consultancy
Ariad, Consultant: Consultancy
Galena, Consultant: Consultancy
Incyte, NA: Research Funding
Gilead, NA: Research Funding
CTI, NA: Research Funding
Promedior, NA: Research Funding
Celgene, NA: Research Funding
Ariad, Consultant: Consultancy
Galena, Consultant: Consultancy
Incyte, NA: Research Funding
Gilead, NA: Research Funding
CTI, NA: Research Funding
Promedior, NA: Research Funding
Celgene, NA: Research Funding
Nothing to Disclose
Nothing to Disclose
Omeros, Clinical Site PI:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
GigaGen Inc, Co-founder:
Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Millennium, Research Funding:
Research Funding
Nothing to Disclose
Nothing to Disclose
Sanofi Oncology, Investigator/Consultancy/Advisory Role:
Consultancy
and
Travel, accommodations, expenses
Kite Pharma, Investigator/Consultancy/Advisory Role: Consultancy
Adaptive Biotechnologies, Investigator/Consultancy/Advisory Role: Consultancy
Genentech, Investigator/Consultancy/Advisory Role: Consultancy
Pharmacyclics, LLC, an AbbVie Company, Investigator/Consultancy/Advisory Role: Consultancy , Intellectual Property Rights , Research Funding , Royalty and Travel, accommodations, expenses
Velos, Investigator/Consultancy/Advisory Role: Consultancy
Kite Pharma, Investigator/Consultancy/Advisory Role: Advisory Board and Consultancy
Adaptive Biotechnologies, Investigator/Consultancy/Advisory Role: Consultancy and Research Funding
Genentech, Investigator/Consultancy/Advisory Role: Consultancy and Research Funding
Sanofi Oncology, Investigator/Consultancy/Advisory Role: Advisory Board , Consultancy and Travel, accommodations, expenses
Pharmacyclics, LLC, an AbbVie Company, Investigator/Consultancy/Advisory Role: Consultancy , Research Funding and Travel, accommodations, expenses
Kite Pharma, Investigator/Consultancy/Advisory Role: Consultancy
Adaptive Biotechnologies, Investigator/Consultancy/Advisory Role: Consultancy
Genentech, Investigator/Consultancy/Advisory Role: Consultancy
Pharmacyclics, LLC, an AbbVie Company, Investigator/Consultancy/Advisory Role: Consultancy , Intellectual Property Rights , Research Funding , Royalty and Travel, accommodations, expenses
Velos, Investigator/Consultancy/Advisory Role: Consultancy
Kite Pharma, Investigator/Consultancy/Advisory Role: Advisory Board and Consultancy
Adaptive Biotechnologies, Investigator/Consultancy/Advisory Role: Consultancy and Research Funding
Genentech, Investigator/Consultancy/Advisory Role: Consultancy and Research Funding
Sanofi Oncology, Investigator/Consultancy/Advisory Role: Advisory Board , Consultancy and Travel, accommodations, expenses
Pharmacyclics, LLC, an AbbVie Company, Investigator/Consultancy/Advisory Role: Consultancy , Research Funding and Travel, accommodations, expenses
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, Speaker:
Honoraria
Novartis, Speaker: Honoraria
Amgen, Speaker: Honoraria
Sanofi, speaker: Honoraria
Takeda, Speaker: Honoraria
Novartis, Speaker: Honoraria
Amgen, Speaker: Honoraria
Sanofi, speaker: Honoraria
Takeda, Speaker: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Astellas, Advisory board participant:
Advisory Board
Jazz, Advisory board participant: Advisory Board
Jazz, Advisory board participant: Advisory Board
Cell and Gene Therapy Catapult UK, Scientific Advisor:
Consultancy
and
Intellectual Property Rights
TxCell, DSMB Member: Honoraria
CellMedica, Research collaboration: Research Funding
TxCell, DSMB Member: Honoraria
CellMedica, Research collaboration: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Oxford Immunotec, None:
Research Funding
GSK, None: Research Funding
GSK, None: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Oxford Immunotec, None:
Research Funding
Merck, None: Research Funding
Shire, None: Research Funding
Chemerix, None: Research Funding
Astella, None: Research Funding
Merck, None: Research Funding
Shire, None: Research Funding
Chemerix, None: Research Funding
Astella, None: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
N
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Study Investigator:
Research Funding
and
Speakers' bureau
Gilead, Consultant: Advisory Board and Consultancy
Gilead, Consultant: Advisory Board and Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis Pharma KK, membership on advisory committees:
Advisory Board
,
Consultancy
and
Honoraria
Mochida Pharmaceutical Co.,Ltd., consulting, independent contractor: Honoraria and Research Funding
Phizer, consulting, speaking and teaching: Consultancy and Honoraria
Mochida Pharmaceutical Co.,Ltd., consulting, independent contractor: Honoraria and Research Funding
Phizer, consulting, speaking and teaching: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Amgen, Advisory Board Attendee:
Consultancy
Seattle Genetics, Advisory Board Attendee: Consultancy
Seattle Genetics, Advisory Board Attendee: Consultancy
Mundipharma, independent contractor:
Research Funding
Nothing to Disclose
Presbyterian /St. Luke's Medical Center, Lead Tech Cellular Therapeutics:
Salary
Nothing to Disclose
Fred Hutchinson Cancer Research Center, former employee:
Royalty
Nothing to Disclose
Nothing to Disclose
Oxford Immunotec, None:
Research Funding
Nothing to Disclose
Nothing to Disclose
Kite Pharma, Employee:
Ownership Interest
and
Salary
Kite Pharma, Employee: Financial Benefit and/or patents and Salary
Kite Pharma, Employee: Financial Benefit and/or patents and Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite Pharma, Member, Consultant, and Recipient:
Advisory Board
,
Consultancy
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix, Inc., Chief Medical Officer:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
PIRCHE AG, Head of Bioinformatics:
Employed
Nothing to Disclose
Celgene, consulting, speaking:
Consultancy
,
Research Funding
and
Speaker's Bureau
Takeda, consulting, speaking: Consultancy , Research Funding and Speaker's Bureau
AMGEN, consulting, speaking: Consultancy , Research Funding and Speaker's bureau
BMS, consulting, speaking: Consultancy , Research Funding and Speaker's bureau
Jenssen, consulting, speaking: Consultancy , Research Funding and speaker's bureau
Takeda, consulting, speaking: Consultancy , Research Funding and Speaker's Bureau
AMGEN, consulting, speaking: Consultancy , Research Funding and Speaker's bureau
BMS, consulting, speaking: Consultancy , Research Funding and Speaker's bureau
Jenssen, consulting, speaking: Consultancy , Research Funding and speaker's bureau
Otsuka Pharmaceuticals, None:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Miltenyi Biotec, employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Walter Nussbaumer, None:
Research Funding
Nothing to Disclose
O
Bristol Myers Squibb, National study Principal Investigator:
Research Funding
Pfizer, Board member: Advisory Board
Glaxo Smith Kline, DSMB: Honoraria
Baxalta, Advisory Board: Advisory Board and Honoraria
Pfizer, Board member: Advisory Board
Glaxo Smith Kline, DSMB: Honoraria
Baxalta, Advisory Board: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Atara Biotherapeutics, Advisory Board:
Research Funding
and
Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Horizon Pharma, none:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
NIH, NCI, medical research scholars program (MRSP) fellow:
Intellectual Property Rights
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lentigen Technology, Employee:
Employee
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
P
Viracor IBT Laboratories, inventor:
Intellectual Property Rights
and
Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck & Co., Inc., employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix, Inc., None:
Advisory Board
and
Investigator
Shire, Consultant: Honoraria
Chimerix, Inc, Consultant: Honoraria
Merck, Inc, Investigator: Research Funding
Astellas, Pharma, Consultant; Investigator: Honoraria and Research Funding
Shire, Consultant: Honoraria
Chimerix, Inc, Consultant: Honoraria
Merck, Inc, Investigator: Research Funding
Astellas, Pharma, Consultant; Investigator: Honoraria and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Vanderbilt University, Employment:
Salary
Nothing to Disclose
Teva, Academic partner:
Research Funding
Seattle Genetics, Academic partner: Research Funding
Takeda, Academic partner: Research Funding
Jassen, Academic partner: Travel funds
Seattle Genetics, Academic partner: Research Funding
Takeda, Academic partner: Research Funding
Jassen, Academic partner: Travel funds
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck & Co., Inc., employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pfizer, consultant:
Advisory Board
and
Honoraria
Baxalta, consultant: Advisory Board
Baxalta, consultant: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi Genzyme, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Speakers bureau:
Honoraria
Celgene, Speakers bureau: Honoraria
Celgene, Speakers bureau: Honoraria
Nothing to Disclose
Point Guard LLC, Director:
Salary
Celgene, Speaker:
Honoraria
Amgen, Speaker: Honoraria
Novartis, Speaker: Honoraria
Seatlle Genetics, speaker: Honoraria
Amgen, Speaker: Honoraria
Novartis, Speaker: Honoraria
Seatlle Genetics, speaker: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celator Pharmaceuticals, Employee:
Stock options/awards
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Oxford Immunotec, None:
Research Funding
Nothing to Disclose
Nothing to Disclose
Gamida Cell Ltd., Employee:
Employment
Gamida Cell Ltd., Employee:
Employment
Nothing to Disclose
Seattle Genetics, Consultant:
Consultancy
Merck, Ad Board: Advisory Board
Incyte, Ad Board: Advisory Board
Servier, Member, DSMB: Member DSMB
Merck, Ad Board: Advisory Board
Incyte, Ad Board: Advisory Board
Servier, Member, DSMB: Member DSMB
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Portola Pharmaceuticals, Stock holder:
stocks
Teva Pharmaceuticals, Consultant: Advisory Board , Consultancy and Honoraria
Teva Pharmaceuticals, Consultant: Advisory Board , Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck, none:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Inc., Stock options:
Former Employee (spouse)
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi, Speaking:
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Clinical Scientist:
Ownership Interest
and
Salary
Seattle Genetics, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Otsuka Pharmaceuticals, None:
Research Funding
Merck & Co., Inc., employee:
Salary
Nothing to Disclose
Pfizer:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
PRA International, None:
Consultancy
Chimerix, Inc., None: Advisory Board
Chimerix, Inc., None: Advisory Board and Investigator
Chimerix, Inc., None: Advisory Board
Chimerix, Inc., None: Advisory Board and Investigator
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharaceuticals, Education:
Presented at Jazz Educational Conference
Chimerix, Advisory Board: Advisory Board
Novartis, Study Steering Committee: Consultancy
Novartis, Study Steering Committee: Advisory Board and Consultancy
Jazz Pharmaceutical: Advisory Board and Consultancy
Medac, Support of International Meeting: They supported housing for an educational meeting
Chimerix, Advisory Board: Advisory Board
Novartis, Study Steering Committee: Consultancy
Novartis, Study Steering Committee: Advisory Board and Consultancy
Jazz Pharmaceutical: Advisory Board and Consultancy
Medac, Support of International Meeting: They supported housing for an educational meeting
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Q
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
R
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Consultancy:
Consultancy
Nothing to Disclose
Seattle Genetics, ad hoc advisory board memeber:
Advisory Board
and
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Recipient:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pfizer:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Oxford Immunotec, Ad board:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Scientist:
Employment
Jazz Pharmaceuticals, Support:
Advisory Board
,
Consultancy
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, Consultancy:
Consultancy
and
Speakers Bureau
Jannsen, Speakers bureau: Speakers bureau
Takeda, Speakers bureau: Consultancy and Speakers bureau
Amgen, Speakers bureau: Consultancy and Speakers bureau
Jannsen, Speakers bureau: Speakers bureau
Takeda, Speakers bureau: Consultancy and Speakers bureau
Amgen, Speakers bureau: Consultancy and Speakers bureau
Juno Therapeutics, Co-founder:
Consultancy
,
Ownership Interest
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Genentec, Speakers Bureau:
Honoraria
Amgen, Speakers Bureau: Honoraria
Amgne, Speakers Bureau: Honoraria
Amgen, Speakers Bureau: Honoraria
Amgne, Speakers Bureau: Honoraria
Nothing to Disclose
Novartis, Independent researcher:
Honoraria
and
Research Funding
Celgene, Independent researcher: Research Funding
Takeda, Independent researcher: Honoraria and Research Funding
Bristol Myers Squibb, Independent researcher: Honoraria and Research Funding
Amgen, Speaker: Honoraria
Celgene, Independent researcher: Research Funding
Takeda, Independent researcher: Honoraria and Research Funding
Bristol Myers Squibb, Independent researcher: Honoraria and Research Funding
Amgen, Speaker: Honoraria
Celgene, Support:
Consultancy
and
Speakers bureau; Travel, Accomodations, and Expenses
Incyte, Support: Consultancy and Speakers bureau
Novartis, Support: Consultancy and Speakers burea; Research funding for my institution; Travel, Accomodations, and Expenses
Pfizer, Support: Consultancy and Research funding for my institution.
Astellas Pharma, Support: Research funding for my institution.
Bristol-Myers Squibb, Support: Research funding for my institution.
NS Pharma, Support: Research funding for my institution.
Incyte, Support: Consultancy and Speakers bureau
Novartis, Support: Consultancy and Speakers burea; Research funding for my institution; Travel, Accomodations, and Expenses
Pfizer, Support: Consultancy and Research funding for my institution.
Astellas Pharma, Support: Research funding for my institution.
Bristol-Myers Squibb, Support: Research funding for my institution.
NS Pharma, Support: Research funding for my institution.
Novartis, Member Advisory Board:
Advisory Board
RA Capital, Consultant: Consultancy
Roche Oncology, Independent Contractor: Research Funding
Clarus Ventures, Consultant: Consultancy
Nektar Therapeutics, Independent contractor: Research Funding
Draper Labs, Consultant: Consultancy
Delinia, Member Advisory Board: Advisory Board
Biothera, Member Advisory Board: Advisory Board
Amgen, Member Advisory Board: Advisory Board
Prometheus Labs, Independent Contractor: Research Funding
RA Capital, Consultant: Consultancy
Roche Oncology, Independent Contractor: Research Funding
Clarus Ventures, Consultant: Consultancy
Nektar Therapeutics, Independent contractor: Research Funding
Draper Labs, Consultant: Consultancy
Delinia, Member Advisory Board: Advisory Board
Biothera, Member Advisory Board: Advisory Board
Amgen, Member Advisory Board: Advisory Board
Prometheus Labs, Independent Contractor: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Terumo BCT, Sr. Scientific Liaison:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
BMS, None:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Onyx, Speaker's bureau:
Honoraria
Janssen, Speaker's bureau: Honoraria
Takeda, Speaker's bureau: Honoraria
Celgene, Speaker's bureau: Honoraria
Janssen, Speaker's bureau: Honoraria
Takeda, Speaker's bureau: Honoraria
Celgene, Speaker's bureau: Honoraria
Kite Pharma, Employee:
Financial Benefit and/or patents
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Oxford Immunotec, None:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, consulting, research:
Consultancy
,
Honoraria
and
Research Funding
Pharmacyclics, research: Honoraria and Research Funding
Seattle Genetics, research: Research Funding
Pharmacyclics, research: Honoraria and Research Funding
Seattle Genetics, research: Research Funding
Alexion Pharmaceuticals, Support:
Speakers bureau
Nothing to Disclose
Novartis, None:
Financial Benefit and/or patents
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
AbbVie, Investor:
Ownership Interest
and
Stocks
University of Rochester, Employee: Ownership Interest , Patent and Royalty
University of Rochester, Employee: Ownership Interest , Patent and Royalty
Nothing to Disclose
Jazz Pharmaceuticals, Employee:
Stock options/awards
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
S
Astellas; Alexion and Spectrum, transplant research:
Honoraria
and
Research Funding
Spectrum, self: Honoraria
Alexion, self: Honoraria
Astellas, self: Research Funding
American Porphyria Foundation, self: fund
Spectrum, self: Honoraria
Alexion, self: Honoraria
Astellas, self: Research Funding
American Porphyria Foundation, self: fund
Nothing to Disclose
Kyte Pharma, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Celgene, Advisory Board:
Advisory Board
and
Honoraria
Novartis, Advisory Board: Advisory Board and Honoraria
Lundbeck, Advisory Board: Advisory Board and Honoraria
Novartis, Advisory Board: Advisory Board and Honoraria
Lundbeck, Advisory Board: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte, Speaker:
Honoraria
Celgene, Speaker: Honoraria
Astellas, Speaker: Honoraria
Sanofi, Speaker: Honoraria
Celgene, Speaker: Honoraria
Astellas, Speaker: Honoraria
Sanofi, Speaker: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead Sciences Inc, Spouse:
Financial Benefit and/or patents
Pfizer, Self: Consultancy
Pfizer, Self: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead, Lead of Phase IIB trial, consultant and recipient of lab funding for murine model project:
Consultancy
and
Research Funding
Pharmacyclics, serve on advisory board for cGVHD trial: Advisory Board
Pharmacyclics, serve on advisory board for cGVHD trial: Advisory Board
Nothing to Disclose
Nothing to Disclose
Sanofi-Genzyme, Consultancy:
Consultancy
and
Research Funding
Juno Therapeutics, Consultancy: Consultancy and Research Funding
Juno Therapeutics, Consultancy: Consultancy and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck, Consultant:
Consultancy
Sunesis, P.I.: Research Funding
Amgen, P.I.: Honoraria and Research Funding
Celgene, P.I.: Honoraria and Research Funding
Sunesis, P.I.: Research Funding
Amgen, P.I.: Honoraria and Research Funding
Celgene, P.I.: Honoraria and Research Funding
Celator, Support:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Miltenyi Biotec, employee:
Salary
Nothing to Disclose
Lentigen Technology, Inc, Employee:
Employee
Nothing to Disclose
Novartis, Speaker:
Honoraria
BMS, Speaker: Honoraria
Amgen, speaker: Honoraria and Ownership Interest
Celgene, speaker: Advisory Board , Honoraria and Ownership Interest
Seattle Genetics, Speaker: Honoraria
Takeda, Speaker: Honoraria
BMS, Speaker: Honoraria
Amgen, speaker: Honoraria and Ownership Interest
Celgene, speaker: Advisory Board , Honoraria and Ownership Interest
Seattle Genetics, Speaker: Honoraria
Takeda, Speaker: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gamida Cell Ltd., Employee:
Employment
Nothing to Disclose
Novartis, Advisor:
Advisory Board
,
Honoraria
and
Research Funding
Celgene, Advisor: Consultancy , Honoraria and Research Funding
Agios, Advisor: Consultancy
Alexion, Speaker: Advisory Board and Honoraria
NORD, Educator: Honoraria
AA/ MDS Organization, Educator: Honoraria
Incyte, Advisor: Consultancy and Honoraria
Celgene, Alexion, Novartis, Speaker: N/A
Celgene, Advisor: Consultancy , Honoraria and Research Funding
Agios, Advisor: Consultancy
Alexion, Speaker: Advisory Board and Honoraria
NORD, Educator: Honoraria
AA/ MDS Organization, Educator: Honoraria
Incyte, Advisor: Consultancy and Honoraria
Celgene, Alexion, Novartis, Speaker: N/A
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Northern Fox Valley Chapter of ONS, Speaker:
Honoraria
Sanofi-Genzyme, Speakers Bureau: Honoraria
Sanofi-Genzyme, Speakers Bureau: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, investigator:
Research Funding
Celgene, Consultant: Advisory Board
Takeda, Consultant: Advisory Board
Celgene, Consultant: Advisory Board
Takeda, Consultant: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Bristol-Myers Squibb, Received research funding:
Research Funding
Sanofi Genzyme, Speaker:
Advisory Board
and
Honoraria
Sanofi, speaker:
Advisory Board
and
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Juno Pharmaceuticals, Advisory Board Member:
Advisory Board
and
Consultancy
Merck, Seattle Genetics, Novartis, Advisory Board participant:
Advisory Board
Novartis, GSK, Otsuka, BMS, Neovii, advisory board participant: Research Funding
Novartis, GSK, Otsuka, BMS, Neovii, advisory board participant: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Oxford Immunotec, Advisory board:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pharmacyclics, Participant:
Speaker's Bureau
Janssen, Participant: Speaker's Bureau
Seattle Genetics, Participant: Speaker's Bureau
Pharmacyclics/Janssen, Member: Speaker's Bureau
Seattle Genetics, Member: Speaker's Bureau
Janssen, Participant: Speaker's Bureau
Seattle Genetics, Participant: Speaker's Bureau
Pharmacyclics/Janssen, Member: Speaker's Bureau
Seattle Genetics, Member: Speaker's Bureau
Nothing to Disclose
Celgene, Speakers Bureau:
Honoraria
and
Speakers Bureau
Angen, Speakers Bureau: Honoraria and Speakers Bureau
Takeda, Speakers Bureau: Honoraria and Speakers Bureau
Novartis, Speakers Bureau: Honoraria and Speakers Bureau
BMS, Speakers Bureau: Honoraria and Speakers Bureau
Merck, Honoraria: Honoraria
Angen, Speakers Bureau: Honoraria and Speakers Bureau
Takeda, Speakers Bureau: Honoraria and Speakers Bureau
Novartis, Speakers Bureau: Honoraria and Speakers Bureau
BMS, Speakers Bureau: Honoraria and Speakers Bureau
Merck, Honoraria: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Viropharma, Site PI:
Research Funding
Shire, Site PI: Research Funding
Shire, Site PI: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Scientist:
Employment
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Abbvie, Consultancy:
Consultancy
Pharmacyclics, Consultancy: Consultancy
Genentech, Speakers bureau: Speakers bureau
Gilead Sciences, Speakers bureau: Speakers bureau
Seattle Genetics, Speakers Bureau: Speakers Bureau
Pharmacyclics, Consultancy: Consultancy
Genentech, Speakers bureau: Speakers bureau
Gilead Sciences, Speakers bureau: Speakers bureau
Seattle Genetics, Speakers Bureau: Speakers Bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Point Guard LLC, Chief Medical Monitor:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Biogen, Independent medical consultant:
Honoraria
Pfizer, Independent medical consultant: travel support
Pfizer, Independent medical consultant: travel support
Nothing to Disclose
Cleveland Clinica, Employee:
Employment
Nothing to Disclose
TG Therapeutics, Consultant:
Consultancy
Portola, Consultant: Consultancy
Celgene, Consultant: Consultancy
Amgen, Internal speaker: gave educational talk to sales force
Gilead, Consultant: Consultancy
Genmab, Consultant: Consultancy
Nanostring, Consultant: Consultancy
Pharmacyclics, Consultant: Consultancy
Roche, Consultant, speaker: Consultancy , DSMB and Honoraria
AbbVie, Consultant: Consultancy
Portola, Consultant: Consultancy
Celgene, Consultant: Consultancy
Amgen, Internal speaker: gave educational talk to sales force
Gilead, Consultant: Consultancy
Genmab, Consultant: Consultancy
Nanostring, Consultant: Consultancy
Pharmacyclics, Consultant: Consultancy
Roche, Consultant, speaker: Consultancy , DSMB and Honoraria
AbbVie, Consultant: Consultancy
Sanofi, Invited speaker:
Honoraria
Jazz, Invited Chair: Honoraria
Jazz, Invited Chair: Honoraria
Gamida Cell Ltd., Employee:
Employment
Merck, Consultant:
Advisory Board
and
Consultancy
Chimerix, Consultant: Consultancy and Honoraria
Chimerix, Consultant: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gentium/Jazz Pharmaceuticals, Support:
Advisory Board
Kiadis, Board member: Consultancy
Novartis, Jazz, Gilead, Juno, Kiadis, Consultant: Honoraria
Kiadis, Board member: Consultancy
Novartis, Jazz, Gilead, Juno, Kiadis, Consultant: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
UMC Utrecht, employee:
listed as inventor on patent owned by UMCU
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi, DSMB:
DSMB - has not begun yet
Nothing to Disclose
Merck & Co., Inc., employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
AbbVie, Support:
Advisory Board
and
Consultancy
Celgene, Support: Advisory Board and Consultancy
Agios, Support: Consultancy
Amgen, Support: Consultancy
Celator, Support: Consultancy
Janssen, Support: Consultancy
Juno Therapeutics, Support: Consultancy
Karyopharm Therapeutics, Support: Consultancy
Merck, Support: Consultancy
Novartis, Support: Consultancy
ONO Pharmaceutical Co., Support: Consultancy
Pfizer, Support: Consultancy
Roche, Support: Consultancy
Seattle Genetics, Support: Consultancy
Sunesis Pharmaceuticals, Support: Consultancy
Xenetic Biosciences, Support: Consultancy
Celgene, Support: Advisory Board and Consultancy
Agios, Support: Consultancy
Amgen, Support: Consultancy
Celator, Support: Consultancy
Janssen, Support: Consultancy
Juno Therapeutics, Support: Consultancy
Karyopharm Therapeutics, Support: Consultancy
Merck, Support: Consultancy
Novartis, Support: Consultancy
ONO Pharmaceutical Co., Support: Consultancy
Pfizer, Support: Consultancy
Roche, Support: Consultancy
Seattle Genetics, Support: Consultancy
Sunesis Pharmaceuticals, Support: Consultancy
Xenetic Biosciences, Support: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Alexion Pharmaceuticals, Support:
Consultancy
Ambit, Support: Consultancy
Baxalta, Support: Consultancy
Boehringer Ingelheim, Support: Consultancy and Research funding for my institution.
CTI Biopharma, Support: Consultancy
Daiichi Sankyo, Support: Consultancy
Sunesis Pharmaceuticals, Support: Consultancy and Research funding for my institution.
AbbVie, Support: Research funding for my institution.
Astellas Pharma, Support: Research funding for my institution.
Cellator, Support: Research funding for my institution.
Cyclacel Pharmaceuticals, Support: Research funding for my institution.
GlaxoSmithKline, Support: Research funding for my institution.
Karyopharm Therapeutics, Support: Research funding for my institution.
Sanofi, Support: Research funding for my institution.
Ambit, Support: Consultancy
Baxalta, Support: Consultancy
Boehringer Ingelheim, Support: Consultancy and Research funding for my institution.
CTI Biopharma, Support: Consultancy
Daiichi Sankyo, Support: Consultancy
Sunesis Pharmaceuticals, Support: Consultancy and Research funding for my institution.
AbbVie, Support: Research funding for my institution.
Astellas Pharma, Support: Research funding for my institution.
Cellator, Support: Research funding for my institution.
Cyclacel Pharmaceuticals, Support: Research funding for my institution.
GlaxoSmithKline, Support: Research funding for my institution.
Karyopharm Therapeutics, Support: Research funding for my institution.
Sanofi, Support: Research funding for my institution.
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sunesis Pharmaceuticals, Support:
Consultancy
,
Honoraria
,
Research Funding
and
Travel, Accomodations, and Expenses
Bayer, Support: Research Funding
ONO Pharmaceutical Co., Support: Consultancy , Research Funding and Travel, Accomodations, and Expenses
Agios, Support: Research Funding
Bristol-Myers Squibb, Support: Research Funding
Celator, Support: Research Funding
Celgene, Support: Research Funding
Merck/Schering Plough, Support: Research Funding
Novartis, Support: Research Funding
Bayer, Support: Research Funding
ONO Pharmaceutical Co., Support: Consultancy , Research Funding and Travel, Accomodations, and Expenses
Agios, Support: Research Funding
Bristol-Myers Squibb, Support: Research Funding
Celator, Support: Research Funding
Celgene, Support: Research Funding
Merck/Schering Plough, Support: Research Funding
Novartis, Support: Research Funding
Nothing to Disclose
Nothing to Disclose
Pharmacyclics, LLC, an AbbVie Company, Employee:
Salary
AbbVie, Employee of Pharmacyclics, LLC, an AbbVie Company: Ownership Interest
AbbVie, Employee of Pharmacyclics, LLC, an AbbVie Company: Ownership Interest
Merck & Co., Inc., employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kiadis Pharma, DSMB member:
Salary
Takeda/Millennium, none: Educational Grant
AstraZeneca, none: Educational Grant
Genentech,Roche, Adjudication member: Salary
Glaxo Smith Klein, none: Research Funding
Merck, none: Research Funding
Takeda/Millennium, none: Educational Grant
AstraZeneca, none: Educational Grant
Genentech,Roche, Adjudication member: Salary
Glaxo Smith Klein, none: Research Funding
Merck, none: Research Funding
Celgene, Speaker:
Honoraria
Boston Scientific, Educator:
Honoraria
Medtronic, Researcher, Educator: Honoraria and Research Funding
Medtronic, Researcher, Educator: Honoraria and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Takeda, Consultancy:
Advisory Board
,
Consultancy
and
Honoraria
BMS, Consultancy: Advisory Board , Consultancy and Honoraria
Gilead, Consultancy: Honoraria
BMS, Consultancy: Advisory Board , Consultancy and Honoraria
Gilead, Consultancy: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Alexion, Speaking and advisory boards:
Advisory Board
and
Honoraria
Ra Pharma, Speaking and advisory boards: Advisory Board and Honoraria
Alnylam, Speaking and advisory board: Advisory Board and Honoraria
Amgen, Speaking and advisory board: Advisory Board and Honoraria
Sanofi-Genzyme, Speaking and advisory board: Advisory Board and Honoraria
Shire, Speaking and advisory board: Advisory Board and Honoraria
Pfizer, Speaking and advisory board: Advisory Board and Honoraria
Ra Pharma, Speaking and advisory boards: Advisory Board and Honoraria
Alnylam, Speaking and advisory board: Advisory Board and Honoraria
Amgen, Speaking and advisory board: Advisory Board and Honoraria
Sanofi-Genzyme, Speaking and advisory board: Advisory Board and Honoraria
Shire, Speaking and advisory board: Advisory Board and Honoraria
Pfizer, Speaking and advisory board: Advisory Board and Honoraria
Nothing to Disclose
T
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jansen:
Husband is employee of Jansen
Janssen, Post-doctoral fellow (spouse): Salary
Janssen, Post-doctoral fellow (spouse): Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Employee:
Stock options/awards
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, None:
Research Funding
Merck, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Speaker:
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis Pharmaceuticals Corporation, Health Economics head:
Employee
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Fresenius Medical Care, Pharmacy Fellow:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kymab, Ltd:
Intellectual Property Rights
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Virginia Commonwealth University, faculty:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead Sciences, Scientiï¬c advisor:
Consultancy
Merck & Co., Inc, Scientiï¬c advisor: Consultancy
Gilead Sciences, Grant: Research Funding
Janssen Pharmaceuticals, Scientiï¬c advisor: Consultancy
Merck & Co., Inc, Scientiï¬c advisor: Consultancy
Gilead Sciences, Grant: Research Funding
Janssen Pharmaceuticals, Scientiï¬c advisor: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
GlaxoSmithKline/Novartis, Collaboration agreement with National Institutes of Health:
Manufacturer of eltrombopag provides drug for clinical research and research funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
ViraCyte LLC, Consultant:
Consultancy
U
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Schulman IRB, IRB Review Consultant:
Consulting Fee
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Boehringer Ingelheim, Support:
Advisory Board
Glycomimetics, Support: Advisory Board
Glycomimetics, Support: Advisory Board
Nothing to Disclose
V
GenDX, Research Collaborator:
Research Funding
Chimerix. Inc., Sr. Medical Director:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pfizer, Consultant/Speaker:
Honoraria
Nothing to Disclose
Nothing to Disclose
Novartis, Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Ablynx, Consultant:
Consultancy
Amgen, Speakers Bureau:
Speakers Bureau
Takeda, Speakers Bureau: Speakers Bureau
Novartis, Speakers Bureau: Speakers Bureau
Janssen, Speakers Bureau: Speakers Bureau
Celgene, Speakers Bureau: Speakers Bureau
Takeda, Speakers Bureau: Speakers Bureau
Novartis, Speakers Bureau: Speakers Bureau
Janssen, Speakers Bureau: Speakers Bureau
Celgene, Speakers Bureau: Speakers Bureau
Health Hive, none:
Honoraria
Chimerix, none: Consultancy
Jazz, none: Honoraria
Chimerix, none: Consultancy
Jazz, none: Honoraria
Jazz Pharmaceuticals, Employee:
Stock options/awards
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Employee:
Stock options/awards
Shire, Employee (at time of study):
Ownership Interest
and
Salary
Viropharma, Employee (current): Ownership Interest and Salary
Viropharma, Employee (current): Ownership Interest and Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Moffitt Cancer Center, Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Takeda, Consultant:
Consultancy
and
Research Funding
Constellation, Research: Research Funding
Celgene, Consultant: Consultancy
Teva, consultant: Consultancy
Calithera, Research: Research Funding
GSK, Research: Research Funding
Acetylon, Research: Research Funding
Karyopharm, Consultant: Consultancy
Constellation, Research: Research Funding
Celgene, Consultant: Consultancy
Teva, consultant: Consultancy
Calithera, Research: Research Funding
GSK, Research: Research Funding
Acetylon, Research: Research Funding
Karyopharm, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pfizer:
Research Funding
Nothing to Disclose
Nothing to Disclose
W
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Aviragen, none:
Research Funding
Gilead Sciences, INC, none: Research Funding
Gilead Sciences, INC, none: Research Funding
Novarits, PI:
Contract
Nothing to Disclose
Nothing to Disclose
Epigenetix Inc., Co-Founder:
Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix, Stock or Other Ownership:
Ownership Interest
Cerus, Stock or Other Ownership: Ownership Interest
Novartis, Investigator/Consultancy/Advisory Role: Consultancy , Honoraria and Research Funding
Helocyte, Investigator/Consultancy/Advisory Role: Consultancy
Cambium, Investigator: Intellectual Property Rights , other relationship , Ownership Interest and Royalty
Cerus, Stock or Other Ownership: Ownership Interest
Novartis, Investigator/Consultancy/Advisory Role: Consultancy , Honoraria and Research Funding
Helocyte, Investigator/Consultancy/Advisory Role: Consultancy
Cambium, Investigator: Intellectual Property Rights , other relationship , Ownership Interest and Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Support:
Consultancy
Nothing to Disclose
Nothing to Disclose
Amneal Biosciences, Medical Science Liason:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kadmon, Consulting:
Honoraria
Enlivex, Consulting: Honoraria
Alexion, Consulting: Research Funding
Enlivex, Consulting: Honoraria
Alexion, Consulting: Research Funding
Nothing to Disclose
Novartis, Consulting:
Consultancy
Janssen, Consulting: Consultancy , Research Funding and travel accommodations
Millennium, Consulting: Consultancy and Travel accommodations
GlaxoSmithKline, Consulting: Consultancy
Prothena, Research: Research Funding and Travel accommodations
Janssen, Consulting: Consultancy , Research Funding and travel accommodations
Millennium, Consulting: Consultancy and Travel accommodations
GlaxoSmithKline, Consulting: Consultancy
Prothena, Research: Research Funding and Travel accommodations
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Forty Seven, Advisory board:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
ProNAI, Member:
Advisory Board
Celgene, Member: Advisory Board
Spectrum, Member: Advisory Board
Chugai, Member: Advisory Board
Celgene, Member: Advisory Board
Spectrum, Member: Advisory Board
Chugai, Member: Advisory Board
Nothing to Disclose
Nothing to Disclose
Omeros Corporation, Chief Medical Officer:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Reata Pharmaceuticals, Investor:
Stocks
Alexion Pharmaceuticals, Support: Honoraria
Sigma-Tau Pharmaceuticals, Support: Research Funding
Alexion Pharmaceuticals, Support: Honoraria
Sigma-Tau Pharmaceuticals, Support: Research Funding
Nothing to Disclose
Kite Pharma, Employee:
Ownership Interest
and
Salary
Kite Pharma, Employee: Financial Benefit and/or patents and Salary
Kite Pharma, Employee: Financial Benefit and/or patents and Salary
Nothing to Disclose
Shire, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
shire, consultant:
Consultancy
gilead, consultant: Consultancy
ansun, consultant: Consultancy
Astellas, consultant: Consultancy
gilead, consultant: Consultancy
ansun, consultant: Consultancy
Astellas, consultant: Consultancy
Nothing to Disclose
Oxford, None:
Research Funding
Merck, None: Consultancy
Chimerix, none: Consultancy
Merck, None: Consultancy
Chimerix, none: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi, Advisory, board, consulting:
Advisory Board
,
Honoraria
,
Research Funding
and
Speaker's fee and travel expenses
Pfizer, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Roche, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Novartis, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
MSD, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Janssen, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Hexal, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Chiesi, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Bristol-Myers Squibb, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Biotest, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Basilea, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Astellas, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Alexion, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Amgen, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
TEVA, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Pfizer, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Roche, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Novartis, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
MSD, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Janssen, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Hexal, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Chiesi, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Bristol-Myers Squibb, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Biotest, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Basilea, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Astellas, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Alexion, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Amgen, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
TEVA, Advisory, board, consulting: Advisory Board , Honoraria , Research Funding and Speaker's fee and travel expenses
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Altor BioScience Corporation, CDO:
Equity
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Neon Therapeuticss, Advisor:
Advisory Board
Lentigen Technology, Inc., employee:
Salary
Nothing to Disclose
Nothing to Disclose
Shire, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
X
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lentigen Technology, Inc., employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi Genzyme, Consultant:
Consultancy
Pharmerit, Employee: Salary
Pharmerit, Employee: Salary
Y
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Bayer, BMS, Celgene, Incyte, Janssen, Sanofi, Seattle Genetics, Takeda Millennium, Genentech, Merck, Speaker:
Honorarium for Speaking Engagements
Novartis, J&J, Curis, Roche, BMS, Research Support: Research Support
Novartis, J&J, Curis, Roche, BMS, Research Support: Research Support
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Moffitt Cancer Center, Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Z
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix Inc., independent investigator:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, Employed:
Equity Ownership
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Moffitt Cancer Center, Employment:
Salary
Nothing to Disclose
Merck & Co., Inc., employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose